Celiac Disease Foundation is a healthcare startup tackling celiac disease, a prevalent genetic autoimmune disease affecting an estimated 3 million Americans, with 70-80% undiagnosed. Founded in 1990, the foundation's mission is to increase diagnosis rates, improve treatments, and ultimately find a cure for the disease. Advocating for more federal funding and public awareness, the foundation strategically invests in research, education, and advocacy to accelerate progress in the field. Their iCureCeliac® patient registry and extensive recruitment services enable them to speed up critical disease research. Moreover, their advocacy efforts have led to federal recognition and research funding from influential agencies such as the U.S. National Institutes of Health and the Department of Defense. With a focus on scientific and ethical standards, the foundation collaborates with partners and stakeholders to drive their mission forward. Overall, Celiac Disease Foundation's strategic approach and achievements highlight its potential for significant impact in the healthcare industry.
There is no investment information
No recent news or press coverage available for Celiac Disease Foundation.